Figure 4B illustrates mIF of a liver biopsy from an epithelial ovarian cancer patient, where there is an observable increase in tumor infiltrating CD8 + and CD4 + T cells, and a decrease in CD56 + and PD-L1 cells after TILT-123 treatment. The gene discussed is CD8A; the disease is neoplasm.